STUDboardsPlay · Research · Self · Fit · Money · Learn · Study · Plan · Token STUDtokenOptional

STUDresearch · Peptide

HGH (Somatropin)

Also known as

Human Growth Hormone · somatropin · GH · rhGH

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗
Peptide Lots of talk Systemic SubQ / IM Growth hormone axis

Systemic GH replacement / abuse context.

What people say Somatropin is recombinant 191-amino-acid human growth hormone. This alias-facing entry covers the same molecule as the fuller HGH record, not a GH secretagogue or HGH fragment. Doses people talk about
Community wellness talkAbout 1–2 IU/day

Off-label clinic and forum language, not a labeled anti-aging indication.

Community physique talkAbout 2–4 IU/day; some threads discuss 4–6+ IU/day

Months-long recomp discussion with more edema, hand and glucose concern as amounts rise; vial content is unverified.

Adult GHD labelingAbout 0.15–0.30 mg/day starting range

GENOTROPIN non-weight-based adult start, individualized in supervised care.

The label individualizes adult replacement by response, adverse effects and IGF-1, while community amounts come from products and stacks that were not independently verified.

Half-life & effect duration

Half-life in the body
  • Genotropin · under-the-skin injectionAbout 3 hours
  • Genotropin · IVAbout 24 minutes
Felt duration people report
  • During useNo effect, water retention, hand symptoms, lethargy, or better / worse sleep
  • Body-change reportsDays-to-months observations, with longer judgments across years
Timing context & sources
How it may feel There is no consistent acute buzz. Inspected users range from little or no perceived effect to early water retention, hand tingling, lethargy, and better or worse sleep; physique judgments usually take months and stacks muddy attribution.
Cycles people discuss Medical GHD replacement is continuous and supervised; physique discussions describe multi-month use. Short on/off folklore and long unsupervised exposure are not equivalent to labeled care. Timing Reported routines include morning-fasted, bedtime and split AM/PM injections, with mid-afternoon use described when other times disrupt sleep or daytime energy. Food-spacing and night-pulse arguments remain community rationales, not established advantages. Stacks Community stacks include insulin or anabolic-androgenic steroids (AAS); this is high-risk use. Access talk Three shelves: brand pens (Genotropin / Norditropin / Omnitrope-class), diverted/pharma-looking kits, and research-chem “191aa” vials. IU labels on gray kits are the authenticity fight. Labs people mention IGF-1 (age-adjusted, same lab) is the exposure surrogate people titrate. Morning draw; some hold the AM pin so fasting glucose isn’t an acute GH artifact. Watch for Edema, carpal tunnel, insulin resistance, IGF-1 risks: Well known.
Related
HGHIGF-1MK-677CJC-1295BPC-157

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

GENOTROPIN labeling measured a mean terminal half-life of 3.0 hours after subcutaneous dosing in adults with GHD.

After 0.03 mg/kg SC, mean Tmax was 5.9 hours and the terminal-half-life 95% confidence interval was 2.2–3.7 hours; an IV study in healthy adults reported about 0.4 hour.

Product-, dose-, route- and population-specific label result; it does not certify gray-market products or every somatropin formulation.

  • DailyMed — GENOTROPIN (somatropin) prescribing information (opens in a new tab)Dosage and Administration; Clinical Pharmacology 12.3 Pharmacokinetics; adult GHD adverse reactions. The label identifies 191-amino-acid somatropin, subcutaneous use, a non-weight adult start around 0.2 mg/day (0.15–0.30 mg/day range), 0.1–0.2 mg/day changes every 1–2 months, and after 0.03 mg/kg SC in adult GHD mean Tmax 5.9 h and terminal half-life 3.0 h (95% CI 2.2–3.7); IV half-life in healthy adults was 0.4 h.Product-specific US prescribing information. The SC PK result is for GENOTROPIN in adult GHD after a weight-based dose and does not make every formulation, population, or gray-market vial exposure-equivalent.

Felt duration people report

The inspected reports do not establish one felt-duration window; null experiences, water retention, hand symptoms, lethargy, and opposing sleep effects all appear.

Reports span days to months and roughly 2–8 IU/day, sometimes split, with longer-term body-composition judgments and multi-year adverse-change anecdotes.

Anonymous retrospective reports, unverified products and amounts, frequent co-use, and no blinded timing assessments. Plasma half-life cannot be substituted for subjective duration.

  • Reddit r/steroids — Compounds: Human Growth Hormone (HGH) (opens in a new tab)Thread and visible first-person replies describing 2–4 IU/day and higher regimens, AM/PM splits, months-long use, null or subtle response, water retention, hand tingling/carpal symptoms, lethargy, sleep differences, a blood-pressure rise during a confounded AAS stack, and multi-year body-change anecdotes.Anonymous retrospective reports with unverified products, varied doses and durations, frequent AAS or other co-use, selection bias, and no controlled attribution. Route and delivered amount are not independently verified.
  • Reddit r/steroids — Compound Experience Thread: HGH (opens in a new tab)Thread and visible first-person replies describing roughly 2–8 IU/day, split schedules, several-month to multi-year runs, water and hand symptoms, better sleep in some, lethargy or little noticeable effect in others, and slowly judged body-composition goals.Anonymous self-reports; products, dosing accuracy, diagnoses, diet, training and concurrent drug use are unverified. Cross-user comments cannot establish prevalence or a causal felt-duration window.

What people say 5

  • Off-label bodycomp lore: Powerful but legally/medically constrained. forum
  • Body-comp talk: HGH (Somatropin) is discussed for recomp, strength continuity, or soft-tissue recovery depending on class. forum
  • Training confound: PRs and scale changes almost always co-travel with diet phase and programming. anecdote
  • Suppression / lipid chatter: Hormonal agents pull bloodwork and PCT conversations even when marketed “mild.” forum
  • Deficient adults/kids: Approved indications. trial

Doses people talk about 7

  • Physique band people actually name: About 2–4 IU/day is the 2025–26 recomp cruise on forums; 4–6+ IU is where split AM+PM and glucose talk jump. forum
  • Conversion shorthand: ~3 IU ≈ 1 mg is the usual chart. Gray kit IU marks are not a certificate. forum
  • If IGF-1 never moves at 2–4 IU: fake/underdosed kit is the first community suspicion before “non-responder.” forum
  • Anti-aging/off-label clinic talk: frequently ~1–2 IU/day community/clinic folklore; higher bodybuilding IU charts also exist. forum
  • Adult GHD replacement (order of magnitude): often ~0.2–1.0 mg/day (~0.6–3 IU/day depending on conversion) individualized. trial
  • Timing: evening SC common in replacement culture; split dosing appears in higher charts. trial
  • Framing: Prescription rHGH — IU charts are medical; gray-market IU claims are unreliable. trial

How it may feel 8

  • Early reports: Some users describe little or no immediate effect; others notice puffiness, ring tightness, hand tingling, lethargy, or deeper or disrupted sleep. Product identity and multi-drug use often confound attribution. forum
  • Months: Bodycomp and IGF-1 changes judged over long periods. forum
  • No reliable acute buzz: Early checkpoints center on injection logistics, water retention, hand symptoms, lethargy, and sleep; body-composition goals are usually judged over months, and some users report no discernible benefit. forum
  • Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
  • Weeks 1–2: First honest checkpoint in self-logs. forum
  • AM lethargy vs PM insomnia: 2025–26 MESO/Reddit split — bedtime can wreck sleep in some; morning can flatten the afternoon. A mid-afternoon pin is the compromise some logs land on. forum
  • Weeks 2–8 water: Rings and shoe tightness often show before any recomp photo. People who feel nothing at 4 IU start asking if the kit is real. forum
  • Months 3–6: Bodycomp and IGF-1 are judged here, not week one. Short “cycles” under-sample the drug. forum

Around the dose 6

  • Clock: Classic medical mimic is bedtime. 2025–26 physique camp often pins AM fasted for lipolysis lore and to leave the night pulse alone. Split AM+PM shows up above ~3–4 IU. forum
  • Empty-ish stomach: Not the secretagogue “insulin blunts the pulse” rule, but AM fasted plus delayed carbs is the fat-loss ritual. Bedtime users still skip a huge late meal for sleep/glucose. forum
  • Training: Not a gym-bag pump peptide. Lift in the day; pin on the chosen clock. Mid-afternoon pins exist when PM wrecks sleep and AM flattens the afternoon. forum
  • Water / carpal: Tight rings or night hand numbness are treated as dose feedback, not a badge. Drop IU before adding a diuretic story. forum
  • After: Protein and lifting still do composition work. Fasting glucose is the next-morning watch. forum
  • Pens vs kits: Brand pens have device math. Underground 191aa kits plus BAC water are a different error surface (IU vs mg). No mix SOP here. forum

Cycles people discuss 4

  • Medical continuous or abuse cycles: Very different risk. forum
  • Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
  • No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
  • Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum

Timing 5

  • Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
  • AM vs PM 2026: Physique camp often prefers AM fasted so the night endogenous pulse stays; clinical/wellness camp still likes bedtime to mimic the nocturnal pulse. IGF-1 often doesn’t pick the winner. forum
  • Split above ~3–4 IU: Higher charts split AM+PM for a smoother IGF-1 curve and less acute water/carpal in those logs. forum
  • GENOTROPIN SC PK: After 0.03 mg/kg subcutaneous somatropin in adult GHD, mean Tmax was 5.9 hours and mean terminal half-life was 3.0 hours (95% CI 2.2–3.7). trial
  • Route contrast: GENOTROPIN labeling reports about 0.4-hour IV half-life in healthy adults versus a 3.0-hour terminal half-life after SC dosing in adult GHD; these are bodily PK clocks, not felt-duration estimates. trial

More on what it is 5

  • Research posture: Educational summary of public discussion and literature themes only. forum
  • How people talk about it: Forum volume is a popularity signal for HGH (Somatropin), not proof it works for you. forum
  • What it is: Recombinant human growth hormone (somatropin) — prescription endocrine drug. trial
  • Duplicate identity: This entry and hgh both describe the same 191-amino-acid somatropin molecule; keep this alias-facing card distinct from secretagogues or fragments. trial
  • Research only: Not approved advice for self-experimentation; legality and access vary by place. forum

Stacks 2

  • With insulin / AAS — high risk culture: community forum
  • Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum

Access talk 5

  • Three shelves: brand pens (Genotropin / Norditropin / Omnitrope-class), diverted/pharma-looking kits, and research-chem “191aa” vials. IU labels on gray kits are the authenticity fight. forum
  • See also the fuller HGH card (`hgh`) for kit/IGF-1 culture. This slug is the same molecule with a somatropin-label emphasis. forum
  • 21 U.S.C. § 333(e): Knowingly distributing, or possessing with intent to distribute, HGH for unauthorized human uses (FDA examples: bodybuilding, anti-aging, athletic enhancement) is a federal offense. This card is discussion only. trial
  • Not in April/July 2026 peptide PCAC headlines. Those votes do not legalize gray somatropin kits. trial
  • Licensed biologic, not a 503A peptide: Imported HGH powder/injection is a finished biologic under PHS Act 351 in FDA Import Alert 66-71 framing — not eligible for the peptide compounding exemptions people copy from BPC/Semax headlines. trial

Labs people mention 3

  • IGF-1 (age-adjusted, same lab) is the exposure surrogate people titrate. Morning draw; some hold the AM pin so fasting glucose isn’t an acute GH artifact. forum
  • If IGF-1 never moves at 2–4 IU: fake/underdosed kit is the first community suspicion before “non-responder.” forum
  • Glucose panel: fasting glucose, A1c, sometimes fasting insulin. GH is diabetogenic in susceptible people — class evidence, not optional flavor text. trial

Storage notes 2

  • No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
  • Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Watch for 10

  • General caution: Research chemical and compounded sources vary; adverse events may be under-reported. forum
  • Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
  • Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
  • Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
  • Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
  • Water / carpal / glucose remain the limiter in 2026 logs. Edema and CTS as “it’s working / too much”; fasting glucose and A1c when IU climbs. forumtrial
  • 191aa vs 192aa: Forums treat 191aa somatropin as the real recombinant; “192aa” on a kit is mostly a quality/authenticity flag. forum
  • US law (not “just another supplement”): HGH is not a typical DEA Schedule III listing, but distributing or possessing it with intent to distribute for non-authorized uses (including bodybuilding or anti-aging) is a separate federal offense. This card maps discussion only — it is not a way to obtain or use HGH, and it promises nothing. trial
  • Edema, carpal tunnel, insulin resistance, IGF-1 risks: Well known. trial
  • Not a 503A peptide. “Compounded HGH” marketing is the identity red flag in 2026 access threads — biologics sit outside that peptide-compounding story. trial

Updated: 2026-09-01

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.
↑ Back to top

All STUDresearch topics →